FDA 483 - Jbc Corp - May 24, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Jbc Corp, a drug repacker in Virginia Beach, VA, was cited with five observations during an FDA inspection from May 20-24, 2019. The inspection revealed significant deficiencies in quality control unit procedures, environmental controls, batch record documentation, employee training, and complaint handling, indicating a lack of fundamental GMP compliance. These issues raise concerns about the identity, strength, quality, and purity of drug products assembled into medical kits.
ID · 5006690a-5e1d-4bdb-87b4-45fd408648a8